期刊文献+

下肢深静脉血栓形成的危险因素和预防措施 被引量:17

下载PDF
导出
摘要 下肢深静脉血栓形成(deep vein thrombosis,DVT)是临床常见的静脉回流障碍性疾病。虽然近年来对DVT的诊断、治疗和预防有了很大的进步,但发病率仍呈逐年上升的趋势[1]。据Aqulia[2]报道,在美国各种疾病死亡的患者中,有DVT者占尸检的72%,每年因肺栓塞(pulmonary embolism,PE)死亡的人数达5~20万,在严重创伤的伤员中,60%并发下肢DVT。
作者 时德
出处 《中国血管外科杂志(电子版)》 2011年第1期5-8,共4页 Chinese Journal of Vascular Surgery(Electronic Version)
  • 相关文献

参考文献32

  • 1张柏根,薛冠华.深静脉血栓形成的病因及高危因素[J].中国实用外科杂志,2003,23(4):197-200. 被引量:216
  • 2程显声,何建国,高明哲,陈光瑾,李树花,张中和,赵鸣武,周素敏,赵济文,成立珠,张珍祥,陈玉林,熊长明.急性肺血栓栓塞症溶栓及抗凝治疗多中心临床分析[J].中华内科杂志,2002,41(1):6-10. 被引量:123
  • 3吕厚山,徐斌.人工关节置换术后下肢深静脉血栓形成[J].中华骨科杂志,1999,19(3):155-156. 被引量:955
  • 4徐宝立,李养琛,尚文娟.鹅头钉治疗股骨转子区骨折的并发症[J].骨与关节损伤杂志,1997,12(1):60-61. 被引量:4
  • 5Kiyoaki Niimi,Masayoshi Kobayashi,Hiroshi Narita,Kiyohito Yamamoto,Kimihiro Komori.Evaluation of the efficacy of venous thromboembolism prophylaxis guideline implementation in Japan[J]. Surgery Today . 2010 (12)
  • 6D. Marsland,S. C. Mears,S. L. Kates.Venous thromboembolic prophylaxis for hip fractures[J]. Osteoporosis International . 2010 (4)
  • 7Stein PD,,Matta F.Epidemiology and incidence:the scope of the problem and risk factors for development of venous thromboembolism. Clinics in Chest Medicine . 2010
  • 8Aqulia AM.Deep venous thvombosis. Journal of Cardiovascular Nursing . 2001
  • 9Lankeit M,Konstantinides S.Mortality risk assessment and the role of thrombolysis in pulmonary embolism. Clinics in Chest Medicine . 2010
  • 10Nikolaou VS,,Bergeron SG,Desy NM,et al.Total knee replacement and chemical thromboprophylaxis:current evidence. Curr Vasc Pharmacol . 2010

二级参考文献8

  • 1张柏根 顾小平 等.下肢深静脉血栓形成后的演变[J].中华外科杂志,1985,23(5):257-257.
  • 2Anderson FA Jr, Wheeler HB, Goldberg RJ, et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.Arch Intern Med,1991,151:933-938.
  • 3Goldhaber SZ.Contemporary pulmonary embolism thrombolysis.Chest,1995,107(1 Suppl):45S-51S.
  • 4Urokinase Pulmonary embolism trial: a national cooperative study. Circulation ,1973, 47:1-108.
  • 5Goldhaber SZ, Kessler CM, Heit J, et al.Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.Lancet,1988,2:293-298.
  • 6Goldhaber SZ. Evolving concepts in thrombolytic therapy for pulmonary embolism.Chest,1992,101(4 Suppl):183S-185S.
  • 7Daniels LB, Parker JA, Patel SR, et al.Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.Am J Cardiol, 1997,80:184-188.
  • 8Arcasoy SM, Kreit JW.Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence.Chest,1999,115:1695-1707.

共引文献1286

同被引文献184

引证文献17

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部